Prevention

Tuberculosis prevention and control efforts rely primarily on the vaccination of infants and the detection and appropriate treatment of active cases. The World Health Organization has achieved some success with improved treatment regimens, and a small decrease in case numbers. The US Preventive Services Task Force (USPSTF) recommends screening people who are at high risk for latent tuberculosis with either tuberculin skin tests or interferon-gamma release assays.

TB education is also necessary for the general public. The public needs to know basic information about TB for a number of reasons including reducing the stigma still associated with TB.

TB prevention consists of two main parts. The first part of TB prevention is to stop the transmission of TB from one adult to another. This is done through firstly, identifying people with active TB, and then curing them through the provision of drug treatment. With proper TB treatment someone with TB will very quickly not be infectious and so can no longer spread the disease to others. The second main part of TB prevention is to prevent people with latent TB from developing active, and infectious, TB disease.

  • TB treatment monitoring
  • First line drugs for TB treatment
  • Diagnosis & resistance Testing
  • TB Prevention

Related Conference of Prevention

March 17-18, 2025

54th World Congress on Microbiology

Berlin, Germany
July 28-29, 2025

17th International Virology Summit

Paris, France
August 25-26, 2025

6th International Conference on Molecular Microbiology

Singapore City, Singapore
September 22-23, 2025

13th World Congress and Expo on Applied Microbiology

Dubai, UAE

Prevention Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in